Bone marrow transplantation versus immunosuppressive therapy in severe aplastic anemia, 1990 - 2001

Archives of Iranian Medicine

Volumn 7, Issue 4, 2004, Pages 272-278

  Ghavamzadeh, Ardeshir ^a   Iravani, Masood ^a   Vafaiezadeh, Farahnaz ^a   Jahani, Mohammad ^a   Mousavi, Asadollah ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antilymphocyte globulin (ALG); Aplastic anemia; Bone marrow transplantation (BMT); Cyclosporin

Indexed keywords

ANDROGEN; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; LYMPHOCYTE ANTIBODY; OXYMETHOLONE; PREDNISOLONE;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHOLESTASIS; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; DONOR; DRUG BLOOD LEVEL; GINGIVA HYPERTROPHY; GRAFT VERSUS HOST REACTION; GROUPS BY AGE; GYNECOMASTIA; HEADACHE; HEMATOLOGY; HLA MATCHING; HOSPITAL SERVICE; HUMAN; HUMAN CELL; HYPERPIGMENTATION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INTERMETHOD COMPARISON; IRAN; KAPLAN MEIER METHOD; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MEDICAL ETHICS; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; PROBABILITY; SEIZURE; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VOMITING;

EID: 14844343477     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Young NS, Barrett AJ. The treatment of severe acquired aplastic anemia. Blood. 1995; 85: 3367-3377.
2. Young NS. Acquired aplastic anemia. Ann Intern Med. 2002; 136: 534-546.
3. de-Medeiros CR, Ribeiro RC, Bittencourt MA, Zanis-Neto J, Pasquini R. Long-term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin. Braz J Med Biol Res. 2000; 33: 553-558.
4. Mollee P, Woodward N, Durrant S, et al. Single institution outcomes of treatment of severe aplastic anemia. Intern Med J. 2001; 31: 337-342.
5. Maciejewski JP, Anderson S, Katevas P, Young NS. Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br J Haematol. 1994; 87: 227-234.
6. Storb R, Etzioni R, Anasetti C, et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood. 1994; 84: 941-949.
7. Killick SB, Marsh JC. Aplastic anaemia: management. Blood Rev. 2000; 14: 157-171.
8. Flinn IW, Kopecky KJ, Foucar MK, et al. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood. 2000; 96: 2981-2986.
9. Frickhofen N, Rosenfeld SJ. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporin. Semin Hematol. 2000; 37: 56-68.
10. Min CK, Kim DW, Lee JW, Han CW, Min WS, Kim CC. Supplemental peripheral blood stem cells to decrease marrow rejection in adult patients with severe aplastic anemia. Am J Hematol. 2002; 69: 15-22.
11. Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporin as treatment for severe acquired aplastic anemia. Blood. 1995; 85: 3058-3065.
12. Bacigalupo A, van Lint MT, Congiu M, Pittaluga PA, Occchini D, Marmont AM. Treatment of severe aplastic anemia in Europe 1970-1985: a report of the SAA Working Party. Bone Marrow Transplant. 1986; 1: 611-615.
13. Gluckman E, Esperou-Bourdeau H, Baruchel A, et al. A multicenter randomized study comparing cyclosporin-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. The cooperative group on the treatment of aplastic anemia. J Autoimmun. 1992; 5 (suppl A): 271-275.
14. Gluckman E, Esperou-Bourdeau H, Baruchel A, et al. Multicenter randomized study comparing cyclosporin-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood. 1992; 79: 2540-2546.
15. Jacobs P, Wood L, Martell RW. Cyclosporin-A in the treatment of severe acute aplastic anaemia. Br J Haematol. 1985; 61: 267-272.
16. Leonard EM, Raefsky E, Griffith P, Kimball J, Nienhuis AW, Young NS. Cyclosporin therapy of aplastic anaemia, congenital and acquired red cell aplasia. Br J Haematol. 1989; 72: 278-284.
17. Frickhofen N, Rosenfeld SJ. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporin. Semin Hematol. 2000; 37: 56-68.
18. Passweg JR, Socie G, Hinterberger W, et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood. 1997; 90: 858-864.
19. Bacigalupo A, Chaple M, Hows J, et al. Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working Party. Br J Haematol. 1993; 83: 145-151.
20. Shahidi NT, Diamond LK. Testosterone-induced remission in aplastic anemia. Am J Dis Child. 1959; 98: 293-302.
21. Shahidi, NT, Diamond LK. Testosterone-induced remission in aplastic anemia of both acquired and congenital types. Further observations in 24 cases. N Engl J Med. 1961; 264: 953-967.
22. Speck B, Tichelli A, Widmer E, et al, Splenectomy as an adjuvant measure in the treatment of severe aplastic anaemia. Br J Haematol. 1996; 92: 818-824.
23. Storb R, Sanders JE, Pepe M, et al. Graft-versus-host disease prophylaxis with methotrexate/cyclosporin in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts. Blood. 1991; 78: 1144-1145.
24. Storb R, Pepe M, Anasetti C, et al. What is the role of prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? Blood. 1990; 76: 1037-1045.
25. Camitta. BM, Thomas ED, Nathan DG, et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood. 1979; 53: 504-514.
26. Camitta BM, O'Reilly RJ, Sensenbrenner L, et al. Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. Blood. 1983; 62: 883-888.
27. Champlin RE, Horowitz MM, van Bekkum DW, et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood. 1989; 73: 606-613.
28. Brodsky RA. High-dose cyclophosphamide treatment for autoimmune disorders. Sci World J. 2002; 2: 1808-1815.
29. Gluckman E, Horowitz MM, Champlin RE, et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood. 1992; 79: 269-275.
30. Deeg HJ, Self S, Storb R, et al. Decreased incidence of marrow graft rejection in patients with severe. aplastic anemia: changing impact of risk factors. Blood. 1986; 68: 1363-1368.
31. Niederwieser D, Pepe M, Storb R, Loughran TP Jr, Longton G. Improvement in rejection, engraftment rate, and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia. Br J Haematol. 1988; 69: 23-28.
32. Schuening F, Bean MA, Deeg HJ, Storb R. Prevention of graft failure in patients with aplastic anemia. Bone Marrow Transplant. 1993; 12 (suppl 3): S48-49.